Contraindicated in:
Use Cautiously in:
CV: bradycardia, heart block, hypertension, orthostatic hypotension.
EENT: macular edema.
GI: ↑liver enzymes, abdominal pain.
Neuro: posterior reversible encephalopathy syndrome (pres), progressive multifocal leukoencephalopathy (pml).
Resp: ↓pulmonary function.
Misc: infection (including bacterial, viral and fungal), MALIGNANCY, hypersensitivity reactions.
Drug-Drug:
Drug-Food:
Absorption: Unknown.
Distribution: Extensively distributed to tissues.
Protein Binding: Ozanimod 98%; CC112273 99.8%; CC1084037 99%.
Metabolism/Excretion: Metabolized by several enzymes into 2 major active metabolites (CC112273 and CC1084037) and 3 minor active metabolites. These metabolites are further converted by multiple enzymes systems. Excreted in feces (37%) and urine (26%), primarily as inactive metabolites.
Half-life: Ozanimod 21 hr; CC112273 and CC1084037 11 days.